EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Therapeutic targeting of CDK12: a medicinal chemistry perspective

Feifei Wang, Hongxue Dai, Kuanxin Wan, Mingliang Wang

Bioorganic & Medicinal Chemistry · 2026

DOI: 10.1016/j.bmc.2026.118552 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioorganic & Medicinal Chemistry, 2026. Verfasst von Feifei Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Zhongshan Institute for Drug Discovery, Chinese Academy of Sciences, Zhongshan 528400, Guangdong, China; School of Chinese Materia Medica, Nanjing Un…. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinases, Protein Kinase Inhibitors, Antineoplastic Agents, Small Molecule Libraries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 125 Literaturangaben. Gefördert von: Shanghai Science and Technology Development Foundation, Natural Science Foundation of Shanghai Municipality, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CDK12 (Cyclin-dependent kinase 12) is a cyclin-dependent kinase that regulates gene transcription by phosphorylating the C-terminal domain of RNA polymerase II, playing a crucial role in maintaining genomic stability. Mutations or alterations in the CDK12 genome can trigger tumorigenesis and progression. Inhibiting the overexpression of CDK12 suppresses tumor growth and proliferation, indicating that it serves both as a biomarker for tumorigenesis and a potential therapeutic target for cancer treatment. In recent years, the structure and biological functions of CDK12 have been progressively elucidated, attracting significant research attention. Currently, the CDK12/13 inhibitor CT7439 is undergoing Phase I/II clinical trials. This paper provides a detailed review of various types of CDK12 small-molecule inhibitors/degraders, primarily based on key structural frameworks. It focuses on exploring the existing structure-activity relationships, aiming to offer a comprehensive perspective for developing highly selective CDK12-targeted inhibitors/degraders and providing valuable insights for future novel drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclin-Dependent KinasesProtein Kinase InhibitorsAntineoplastic AgentsSmall Molecule LibrariesHumansStructure-Activity RelationshipChemistry, PharmaceuticalMolecular StructureAnimals

Stichwörter der Autor:innen

CDK12DegraderInhibitorMedical chemistry

Substanzen

Cyclin-Dependent KinasesCDK12 protein, humanProtein Kinase InhibitorsAntineoplastic AgentsSmall Molecule Libraries

Autor:innen und Institutionen

  • Zhongshan Institute for Drug Discovery, Chinese Academy of Sciences, Zhongshan 528400, Guangdong, China; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • Zhongshan Institute for Drug Discovery, Chinese Academy of Sciences, Zhongshan 528400, Guangdong, China; School of Pharmacy, Fudan University, Shanghai 201203, China.
  • Zhongshan Institute for Drug Discovery, Chinese Academy of Sciences, Zhongshan 528400, Guangdong, China; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, Guangdong, China.
  • Zhongshan Institute for Drug Discovery, Chinese Academy of Sciences, Zhongshan 528400, Guangdong, China; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; School of Chinese Mater…

Förderung

  • Shanghai Science and Technology Development Foundation
  • Natural Science Foundation of Shanghai Municipality
  • China Postdoctoral Science Foundation

Zitieren

APA

Wang, F., Dai, H., Wan, K., & Wang, M. (2026). Therapeutic targeting of CDK12: a medicinal chemistry perspective. Bioorganic & Medicinal Chemistry. https://doi.org/10.1016/j.bmc.2026.118552

Vancouver

Wang F, Dai H, Wan K, Wang M. Therapeutic targeting of CDK12: a medicinal chemistry perspective. Bioorganic & Medicinal Chemistry. 2026. doi:10.1016/j.bmc.2026.118552

BibTeX
@article{Wang2026,
  author = {Wang, Feifei and Dai, Hongxue and Wan, Kuanxin and Wang, Mingliang},
  title = {Therapeutic targeting of CDK12: a medicinal chemistry perspective},
  journal = {Bioorganic & Medicinal Chemistry},
  year = {2026},
  doi = {10.1016/j.bmc.2026.118552}
}
Kostenlos starten →